Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2017 03:05 ET | Source: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project

VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...
August 08, 2017 03:05 ET | Source: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics

VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
August 01, 2017 08:30 ET | Source: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange

VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...
July 25, 2017 08:30 ET | Source: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Launches Phase One of Venom Re-Engineering Project

VANCOUVER, British Columbia, July 25, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the launch of the Company’s multi-faceted Research...
July 17, 2017 08:30 ET | Source: PreveCeutical Medical Inc

PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity

VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces, further to its news release dated April 13, 2017,...
May 17, 2017 16:30 ET | Source: PreveCeutical Medical Inc

Update: PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc....
May 17, 2017 09:00 ET | Source: PreveCeutical Medical Inc

PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
April 24, 2017 08:30 ET | Source: PreveCeutical Medical Inc

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels

VANCOUVER, British Columbia, April 24, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilising nature and science for the benefit of...
April 20, 2017 09:00 ET | Source: PreveCeutical Medical Inc

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides

VANCOUVER, British Columbia, April 20, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
April 13, 2017 09:00 ET | Source: PreveCeutical Medical Inc

PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited

VANCOUVER, British Columbia, April 13, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...

Next Page keyboard_arrow_right